ACCENTIS NV (ACCB.BR) Fundamental Analysis & Valuation

EBR:ACCB • BE0003696102

Current stock price

0.0285 EUR
+0 (+9.62%)
Last:

This ACCB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ACCB.BR Profitability Analysis

1.1 Basic Checks

  • ACCB had negative earnings in the past year.
  • ACCB had a positive operating cash flow in the past year.
  • ACCB had positive earnings in each of the past 5 years.
  • In the past 5 years ACCB always reported a positive cash flow from operatings.
ACCB.BR Yearly Net Income VS EBIT VS OCF VS FCFACCB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

  • ACCB's Return On Assets of 2.19% is fine compared to the rest of the industry. ACCB outperforms 64.18% of its industry peers.
  • The Return On Equity of ACCB (3.19%) is comparable to the rest of the industry.
  • With an excellent Return On Invested Capital value of 4.82%, ACCB belongs to the best of the industry, outperforming 86.57% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ACCB is in line with the industry average of 4.20%.
Industry RankSector Rank
ROA 2.19%
ROE 3.19%
ROIC 4.82%
ROA(3y)2.64%
ROA(5y)4.66%
ROE(3y)3.95%
ROE(5y)6.29%
ROIC(3y)4.93%
ROIC(5y)5.34%
ACCB.BR Yearly ROA, ROE, ROICACCB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 20.50%, ACCB is in the better half of the industry, outperforming 65.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ACCB has declined.
  • ACCB has a better Operating Margin (59.84%) than 82.09% of its industry peers.
  • In the last couple of years the Operating Margin of ACCB has grown nicely.
  • With a decent Gross Margin value of 60.22%, ACCB is doing good in the industry, outperforming 61.19% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACCB has grown nicely.
Industry RankSector Rank
OM 59.84%
PM (TTM) 20.5%
GM 60.22%
OM growth 3Y5.89%
OM growth 5Y2.76%
PM growth 3Y68.71%
PM growth 5Y-5.89%
GM growth 3Y5.55%
GM growth 5Y2.67%
ACCB.BR Yearly Profit, Operating, Gross MarginsACCB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ACCB.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACCB is destroying value.
  • Compared to 1 year ago, ACCB has about the same amount of shares outstanding.
  • ACCB has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ACCB has been reduced compared to a year ago.
ACCB.BR Yearly Shares OutstandingACCB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ACCB.BR Yearly Total Debt VS Total AssetsACCB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

  • An Altman-Z score of 2.25 indicates that ACCB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ACCB's Altman-Z score of 2.25 is amongst the best of the industry. ACCB outperforms 88.06% of its industry peers.
  • ACCB has a debt to FCF ratio of 3.31. This is a good value and a sign of high solvency as ACCB would need 3.31 years to pay back of all of its debts.
  • ACCB has a Debt to FCF ratio of 3.31. This is amongst the best in the industry. ACCB outperforms 92.54% of its industry peers.
  • ACCB has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • ACCB has a better Debt to Equity ratio (0.24) than 77.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.31
Altman-Z 2.25
ROIC/WACC0.7
WACC6.94%
ACCB.BR Yearly LT Debt VS Equity VS FCFACCB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 6.53 indicates that ACCB has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 6.53, ACCB belongs to the top of the industry, outperforming 92.54% of the companies in the same industry.
  • A Quick Ratio of 6.53 indicates that ACCB has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 6.53, ACCB belongs to the best of the industry, outperforming 94.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.53
Quick Ratio 6.53
ACCB.BR Yearly Current Assets VS Current LiabilitesACCB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ACCB.BR Growth Analysis

3.1 Past

  • ACCB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.50%.
  • ACCB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.30% yearly.
  • The Revenue has decreased by -3.37% in the past year.
  • Measured over the past years, ACCB shows a very negative growth in Revenue. The Revenue has been decreasing by -22.00% on average per year.
EPS 1Y (TTM)-37.5%
EPS 3Y49.38%
EPS 5Y-26.3%
EPS Q2Q%100%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y-8.7%
Revenue growth 5Y-22%
Sales Q2Q%-4.1%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACCB.BR Yearly Revenue VS EstimatesACCB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

2

4. ACCB.BR Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ACCB.BR Price Earnings VS Forward Price EarningsACCB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, ACCB is valued a bit cheaper than 71.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.02
EV/EBITDA N/A
ACCB.BR Per share dataACCB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.01 0.02 0.03

4.3 Compensation for Growth

  • ACCB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACCB.BR Dividend Analysis

5.1 Amount

  • No dividends for ACCB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACCB.BR Fundamentals: All Metrics, Ratios and Statistics

ACCENTIS NV

EBR:ACCB (4/13/2026, 7:00:00 PM)

0.0285

+0 (+9.62%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap35.99M
Revenue(TTM)6.25M
Net Income(TTM)1.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.76
P/FCF 10.02
P/OCF 10.01
P/B 0.9
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY9.98%
OCF(TTM)0
OCFY9.99%
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.19%
ROE 3.19%
ROCE 6.81%
ROIC 4.82%
ROICexc 7.91%
ROICexgc 7.91%
OM 59.84%
PM (TTM) 20.5%
GM 60.22%
FCFM 57.49%
ROA(3y)2.64%
ROA(5y)4.66%
ROE(3y)3.95%
ROE(5y)6.29%
ROIC(3y)4.93%
ROIC(5y)5.34%
ROICexc(3y)7.56%
ROICexc(5y)8.9%
ROICexgc(3y)7.56%
ROICexgc(5y)8.9%
ROCE(3y)6.95%
ROCE(5y)7.52%
ROICexgc growth 3Y7.47%
ROICexgc growth 5Y5.72%
ROICexc growth 3Y7.47%
ROICexc growth 5Y5.72%
OM growth 3Y5.89%
OM growth 5Y2.76%
PM growth 3Y68.71%
PM growth 5Y-5.89%
GM growth 3Y5.55%
GM growth 5Y2.67%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.31
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.05%
Interest Coverage 4.86
Cash Conversion N/A
Profit Quality 280.48%
Current Ratio 6.53
Quick Ratio 6.53
Altman-Z 2.25
F-Score5
WACC6.94%
ROIC/WACC0.7
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.1%
Profit Quality(3y)290.73%
Profit Quality(5y)339.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-37.5%
EPS 3Y49.38%
EPS 5Y-26.3%
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y-8.7%
Revenue growth 5Y-22%
Sales Q2Q%-4.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.02%
EBIT growth 3Y-3.33%
EBIT growth 5Y-19.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.98%
FCF growth 3Y3.32%
FCF growth 5Y-23.68%
OCF growth 1Y13.94%
OCF growth 3Y3.35%
OCF growth 5Y-23.66%

ACCENTIS NV / ACCB.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ACCENTIS NV (ACCB.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ACCB.BR.


What is the valuation status of ACCENTIS NV (ACCB.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to ACCENTIS NV (ACCB.BR). This can be considered as Overvalued.


Can you provide the profitability details for ACCENTIS NV?

ACCENTIS NV (ACCB.BR) has a profitability rating of 7 / 10.


Is the dividend of ACCENTIS NV sustainable?

The dividend rating of ACCENTIS NV (ACCB.BR) is 0 / 10 and the dividend payout ratio is 0%.